section 8
on 26 Jan 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
87143159 filed on 18th Aug 2016
Registration Number
5239909 registered on 11th Jul 2017
Correspondent Address
CAMILLE M. MILLER
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
No 87143159
No Service/Collective Mark
No 365576/CELG-
Yes
No
Yes
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 26th Jan 2024 | CANCELLED SEC. 8 (6-YR) |
| 11th Jul 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 11th Jul 2017 | REGISTERED-PRINCIPAL REGISTER |
| 02th Jun 2017 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 19th May 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th May 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th May 2017 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 02th May 2017 | NOTICE OF ALLOWANCE CANCELLED |
| 07th Mar 2017 | PUBLISHED FOR OPPOSITION |
| 07th Mar 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
